{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-088380","form_type":"8-K","ticker":"LIMN","cik":"0001971387","company_name":"Liminatus Pharma, Inc.","filed_at":"2026-07-30T01:49:15+00:00","discovered_at":"2026-07-30T10:05:00.260508+00:00","generated_at":"2026-07-30T10:05:05.066409+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Liminatus Pharma believes it meets Nasdaq equity minimum after InnocsAI merger","bullets":["Company believes stockholders' equity now exceeds $2.5 million following merger with InnocsAI LLC.","Awaiting Nasdaq compliance determination; Nasdaq will continue to monitor compliance.","If next periodic report does not show compliance, Company may face future delisting.","Merger with InnocsAI LLC previously announced; no further deal terms disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-088380","json":"https://secwatch.observer/filing/0001104659-26-088380.json","markdown":"https://secwatch.observer/filing/0001104659-26-088380.md","text":"https://secwatch.observer/filing/0001104659-26-088380.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926088380/0001104659-26-088380-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926088380/tm2621658d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-30T10:05:05.066409+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}